Plaschke, K., Petersen, K. A., Frankenhauser, S., Weigand, M. A., Kopitz, J., & Bardenheuer, H. J. (2016). The impact of plasma cholinergic enzyme activity and other risk factors for the development of delirium in patients receiving palliative care. Journal of pain and symptom management, 52(4), . https://doi.org/10.1016/j.jpainsymman.2016.05.015
Chicago Style (17th ed.) CitationPlaschke, Konstanze, Katharina Angelika Petersen, Susanne Frankenhauser, Markus A. Weigand, Jürgen Kopitz, and Hubert J. Bardenheuer. "The Impact of Plasma Cholinergic Enzyme Activity and Other Risk Factors for the Development of Delirium in Patients Receiving Palliative Care." Journal of Pain and Symptom Management 52, no. 4 (2016). https://doi.org/10.1016/j.jpainsymman.2016.05.015.
MLA (9th ed.) CitationPlaschke, Konstanze, et al. "The Impact of Plasma Cholinergic Enzyme Activity and Other Risk Factors for the Development of Delirium in Patients Receiving Palliative Care." Journal of Pain and Symptom Management, vol. 52, no. 4, 2016, https://doi.org/10.1016/j.jpainsymman.2016.05.015.